Skip to search formSkip to main contentSkip to account menu

Familial Partial Lipodystrophy, Type 3

Known as: FPLD3, Lipodystrophy, Familial Partial, Associated With PPARg Mutations, Lipodystrophy, Familial Partial, Type 3 
This type can be caused by mutation in the gene encoding PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The Ala allele of PPARG Pro12Ala ( rs1801282 ) is associated with greater improvements to the glucose metabolism in exercise… 
Review
2019
Review
2019
Objective To analyze the clinical features of familial partial lipodystrophy type 3 (FPLD3) with recurrent pancreatitis and its… 
2015
2015
Peroxisome proliferator-activated receptor gamma (PPARG) is related to inflammation and plays an important role in the… 
2014
2014
The aim of this study was to evaluate the effects of short-term creatine supplementation on exercise performance in male athletes… 
2014
2014
Background:Chronic inflammation and obesity may contribute to the genesis or progression of BPH and BPH-associated lower urinary… 
2010
2010
OBJECTIVES To examine the relationship between polymorphisms of five candidate genes for type 2 diabetes mellitus (T2DM) and the… 
2009
2009
A new method (termed as “chip‐BAMPER” (bioluminometric assay coupled with modified primer extension reactions)) for single… 
2008
2008
Background.The correlation of gene variants with biological variables or clinical assessments has not been well understood… 
Review
2007
Review
2007
AIM One putative determinant of diabetic nephropathy is the Pro12Ala (P12A) polymorphism in the gene encoding peroxisome…